Akari Therapeutics (AKTX) | Q1 2014 | 3,656,238.03% |
Processa Pharmaceuticals (PCSA) | Q1 2014 | 2,041,566.67% |
Empire Petroleum (EP) | Q1 2014 | 1,020% |
Lexaria Bioscience (LEXX) | Q1 2014 | 680.96% |
SurgePays (SURG) | Q1 2014 | 471.43% |
Ainos (AIMD) | Q1 2014 | 433.33% |
CEA Industries (BNC) | Q1 2014 | 419.87% |
Live Ventures (LIVE) | Q1 2014 | 405.42% |
Perspective Therapeutics (CATX) | Q1 2014 | 348.98% |
Green Brick Partners (GRBK) | Q1 2014 | 326.91% |
Applied Digital (APLD) | Q1 2014 | 300% |
Lithium Argentina (LAR) | Q1 2014 | 277.05% |
Plug Power (PLUG) | Q1 2014 | 244.66% |
PharmaCyte Biotech (PMCB) | Q1 2014 | 219.96% |
Alto Ingredients (ALTO) | Q1 2014 | 205.49% |
Travere Therapeutics (TVTX) | Q1 2014 | 194.85% |
Ryvyl (RVYL) | Q1 2014 | 190.14% |
Arbutus Biopharma (ABUS) | Q1 2014 | 170.31% |
Ballard Power Systems (BLDP) | Q1 2014 | 169.94% |
Capricor Therapeutics (CAPR) | Q1 2014 | 163.98% |
Optex Systems Holdings, Inc Common Stock (OPXS) | Q1 2014 | 160% |
CEL-SCI (CVM) | Q1 2014 | 157.63% |
POET Technologies (POET) | Q1 2014 | 150% |
Nextplat (NXPL) | Q1 2014 | 150% |
Abeona Therapeutics (ABEO) | Q1 2014 | 134.04% |
